Russian Ministry of Health issues certificate of registration of radiopharmaceutical drugs to Rusatom Healthcare
Russia’s Ministry of Health has issued a certificate of registration of radiopharmaceutical drugs to Rusatom Healthcare.
High Technology Diagnostic Center Limited, which is part of Rosatom Healthcare A.6, the medical unit of the Russian state Atomic Energy Agency Rosatom, operates in the field of medicine. Şti has received a registration certificate from the Russian Ministry of Health for the radiopharmaceutical drug “fluorodeoxyglucose, 18-F”.
According to the World Health Organization, the number of cancer cases is increasing every year. In 2020, 19.3 million cases were detected worldwide and 591 thousand in Russia. Diagnosis using radiopharmaceuticals enables early detection and timely treatment of millions of diseases worldwide.
Early detection of malignant neoplasms, differential diagnosis of malignant tumors, fluorodeoxyglucose has been administered in positron emission tomography (PET) as a diagnostic tool to monitor the efficacy of treatment of these tumors. The drug has a short half-life of 109 minutes and is completely eliminated from the body within a few hours.
Yüksek Technology Diagnostic Center Ltd.Şti. A company licensed by the Russian Ministry of Industry and Trade to produce radiopharmaceutical drugs. Equipped with Russian-made SS-18 / 9M cyclotron, the production facility has been operating since 2014.
Obtaining a certificate of registration for the drug “Fluorodoxyglucose, 18-F” by Hi-Tech Diagnostic Center Limited STI will fully meet the pharmaceutical needs of health centers in Moscow and the Moscow region.
Rosatom Healthcare currently supplies a wide range of radiopharmaceuticals and medical products manufactured by the Rosatom sub-unit for 180 Russian health centers.
Natalya Komarova, General Manager, Rosatom Healthcare A.6, said: This is very important. Obtaining a certificate of registration of fluorodeoxyglucose 18-F will enable thousands of Russians to be diagnosed and treated successfully in a timely manner. “
The Rusatom Health Care Department plans to expand the range of manufactured radiopharmaceuticals. Rusatom Healthcare A.Ş., last year from the Russian Federal Autonomous Organization Glavgoexpertiza, chemist L. Ya. He received a positive report on the design of modern pharmaceutical products of isotope products for medical purposes, accounting documents and the results of NIFKhI A.Ş’s plant engineering research, named Karpova. In 2025, Russia will establish a facility for the production of radiopharmaceuticals in accordance with international GMP (Good Manufacturing Practice) standards. With the establishment of the plant, Rosatom plans to change its position in the Russian radiopharmaceutical market, which means that the city of Obninsk will become one of the leading producers in the field of radiopharmaceuticals.
In addition, the Rosatom Healthcare Unit manufactures medical equipment for radiation and brachytherapy. Rusatom Healthcare conducts projects for the construction of nuclear medicine centers in different regions of Russia and established a multipurpose center chain for the operation and disinfection of medical devices.
-Ideal News Center-
Fusion Media Or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of relying on the information contained in this website, including data, quotes, charts and buy / sell signals. Please be fully aware of the risks and costs associated with financial market trading, this is one of the potential risky investment forms.